Top

Published in:

Open Access 01-03-2017 | Original Article

A nurse-led sexual rehabilitation intervention after radiotherapy for gynecological cancer

Authors: R. M. Bakker, J. W. M. Mens, H. E. de Groot, C. C. Tuijnman-Raasveld, C. Braat, W. C. P. Hompus, J. G. M. Poelman, M. S. Laman, L. A. Velema, C. D. de Kroon, H. C. van Doorn, C. L. Creutzberg, M. M. ter Kuile

Published in: Supportive Care in Cancer | Issue 3/2017

Abstract

Purpose

Although vaginal dilator use after combined pelvic radiation therapy and brachytherapy (RT/BT) is recommended to prevent vaginal shortening and stenosis, women fail to use them and experience sexual problems. A nurse-led sexual rehabilitation intervention targeting sexual recovery and vaginal dilatation was developed. Its feasibility was investigated during a prospective, longitudinal, observational pilot study.

Methods

Four oncology nurses were specifically trained to conduct the intervention. Gynecologic cancer patients treated with RT/BT were assessed using (i) questionnaires on frequency of dilator use (monthly), sexual functioning, and sexual distress (at baseline and 1, 6, and 12 months) and psychological and relational distress (at 1, 6, and 12 months); (ii) semi-structured interviews (between 6 and 12 months); and (iii) consultation recordings (a random selection of 21 % of all consults).

Results

Twenty participants were 26–71 years old (mean = 40). Eight participants discontinued participation after 3 to 9 months. At 6 months after RT, 14 out of 16 (88 %), and at 12 months 9 out of 12 (75 %), participants dilated regularly, either by having sexual intercourse or by using dilators. Sexual functioning improved between 1 and 6 months after RT, with further improvement at 12 months. Most participants reported that the intervention was helpful and the nurses reported having sufficient expertise and counseling skills.

Conclusions

According to the pilot results, the intervention was feasible and promising for sexual rehabilitation and regular dilator use after RT. Its (cost-)effectiveness will be investigated in a randomized controlled trial.

Available only for authorised users

Dutch Cancer Registry (2015) Vereniging van Integrale Kankercentra. Available at http://www.cijfersoverkanker.nl. Last accessed 21st of March 2016

Waggoner SE (2003) Cervical cancer. Lancet 361:2217–2225. doi:10.1016/S0140-6736(03)13778-6 CrossRefPubMed

Vale C (2008) Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 26:5802–5812. doi:10.1200/JCO.2008.16.4368 CrossRef

Rijkmans EC, Nout RA, Rutten IHHM, Ketelaars M, Neelis KJ, Laman MS, Coen VIMA, Gaarenstroom KN, Kroep JR, Creutzberg CL (2014) Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy. Gynecol Oncol 135:231–238. doi:10.1016/j.ygyno.2014.08.027 CrossRefPubMed

Gilbert E, Ussher JM, Perz J (2011) Sexuality after gynaecological cancer: a review of the material, intrapsychic, and discursive aspects of treatment on women’s sexual-wellbeing. Maturitas 70:42–57. doi:10.1016/j.maturitas.2011.06.013 CrossRefPubMed

Jensen PT, Froeding LP (2015) Pelvic radiotherapy and sexual function in women. Transl Androl Urol 4:186–205. doi:10.3978/j.issn.2223-4683.2015.04.06 PubMedPubMedCentral

Kirchheiner K, Potter R, Tanderup K, Lindegaard JC, Haie-Meder C, Petric P, Mahantshetty U, Jurgenliemk-Schulz IM, Rai B, Cooper R, Dorr W, Nout RA (2016) Health-related quality of life in locally advanced cervical cancer patients after definitive chemoradiation therapy including image guided adaptive brachytherapy: an analysis from the EMBRACE study. Int J Radiat Oncol Biol Phys 94:1088–1098. doi:10.1016/j.ijrobp.2015.12.363 CrossRefPubMed

Le Borgne G, Mercier M, Woronoff AS, Guizard AV, Abeilard E, Caravati-Jouvenceaux A, Klein D, Velten M, Joly F (2013) Quality of life in long-term cervical cancer survivors: a population-based study. Gynecol Oncol 129:222–228. doi:10.1016/j.ygyno.2012.12.033 CrossRefPubMed

Pieterse QD, Kenter GG, Maas CP, de Kroon CD, Creutzberg CL, Trimbos JBM, ter Kuile MM (2013) Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: longitudinal prospective cohort study. Int J Gynecol Cancer 23:1717–1725. doi:10.1097/IGC.0b013e3182a80a65 CrossRefPubMed

10.

Bakker RM, Kenter GG, Creutzberg CL, Stiggelbout, AM, Derks M, Mingelen W, de Kroon CD, Vermeer WM, ter Kuile, MM. Sexual distress and associated factors among cervical cancer survivors: a cross-sectional multicentre observational study. Submitted for publication in 2016

11.

Brand AH, Bull CA, Cakir B (2006) Vaginal stenosis in patients treated with radiotherapy for carcinoma of the cervix. Int J Gynecol Cancer 16:288–293. doi:10.1111/j.1525-1438.2006.00348.x CrossRefPubMed

12.

Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D (2003) Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. Int J of Rad Oncol Biol Phys 56:937–949. doi:10.1016/S0360-3016(03)00362-6 CrossRef

13.

Decruze SB, Guthrie D, Magnani R (1999) Prevention of vaginal stenosis in patients following vaginal brachytherapy. Clin Oncol 11:46–48CrossRef

14.

Gondi V, Bentzen SM, Sklenar KL, Dunn EF, Petereit DG, Tannehill SP, Straub M, Bradley KA (2012) Severe late toxicities following concomitant chemoradiotherapy compared to radiotherapy alone in cervical cancer: an inter-era analysis. Int J Radiat Oncol Biol Phys 84:973–982. doi:10.1016/j.ijrobp.2012.01.064 CrossRefPubMedPubMedCentral

15.

Law E, Kelvin JF, Thom B, Riedel E, Tom A, Carter J, Alektiar KM, Goodman KA (2015) Prospective study of vaginal dilator use adherence and efficacy following radiotherapy. Radiother Oncol 116:149–155. doi:10.1016/j.radonc.2015.06.018 CrossRefPubMedPubMedCentral

16.

Miles T, Johnson N (2014) Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database Syst Rev 9:CD007291. doi:10.1002/14651858.CD007291.pub3

17.

Velaskar SM, Martha R, Mahantashetty U, Badakare JS, Shrivastava SK (2007) Use of indigenous vaginal dilator in radiation induced vaginal stenosis. Indian J Occup Ther 39:3–6

18.

Bakker RM, ter Kuile MM, Vermeer WM, Nout RA, Mens JW, van Doorn LC, de Kroon CD, Hompus WC, Braat C, Creutzberg CL (2014) Sexual rehabilitation after pelvic radiotherapy and vaginal dilator use: consensus using the Delphi method. Int J Gynecol Cancer 24:1499–1506. doi:10.1097/IGC.0000000000000253 CrossRefPubMed

19.

Clinical Guideline group. International Guidelines on Vaginal Dilation after Pelvic Radiotherapy. http://www.ncsi.org.uk/wp-content/uploads/Inter-Best-Practice-Guide-Vaginal-Dilators-July-2012.pdf. 2012. Oxon, Owen Mumford

20.

Bakker RM, Vermeer WM, Creutzberg CL, Mens JW, Nout RA, ter Kuile MM (2015) Qualitative accounts of patients’ determinants of vaginal dilator use after pelvic radiotherapy. J Sex Med 12:764–773. doi:10.1111/jsm.12776 CrossRefPubMed

21.

Brand AH, Do V, Stenlake A (2012) Can an educational intervention improve compliance with vaginal dilator use in patients treated with radiation for a gynecological malignancy? Int J Gynecol Cancer 22:897–904. doi:10.1097/IGC.0b013e31824d7243 CrossRefPubMed

22.

Friedman LC, Abdallah R, Schluchter M, Panneerselvam A, Kunos A (2011) Adherence to vaginal dilation following high dose rate brachytherapy for endometrial cancer. Int J Radiat Oncol Biol Phys 80:751–757. doi:10.1016/j.ijrobp.2010.02.058 CrossRefPubMed

23.

Juraskova I, Lubotzky F (2015) Recovering after pelvic radiation therapy: a guide for women Available from: http://www.targetingcancer.com.au/wp-content/uploads/2015/10/Recovering-after-Pelvic-Radiation-Therapy-a-guide-for-women.pdf

24.

Lubotzky F (2014) The development, pilot and randomised controlled trial of a psychosexual rehabilitation information booklet for women undergoing pelvic radiation therapy for gynaecological or anorectal cancer. Online published PhD thesis available from: http://ses.library.usyd.edu.au/handle/2123/12819

25.

Lubotzky F, Butow P, Nattress K, Hunt C, Carroll S, Comensoli A, Philp S, Juraskova I (2015) Facilitating psychosexual adjustment for women undergoing pelvic radiotherapy: pilot of a novel patient psycho-educational resource. Health Expect:1–12. doi:10.1111/hex.12424

26.

Jeffries SA, Robinson JW, Craighead PS, Keats MR (2006) An effective group psychoeducational intervention for improving compliance with vaginal dilation: a randomized controlled trial. Int J Rad Oncol Biol Phys 65:404–411. doi:10.1016/j.ijrobp.2005.12.009 CrossRef

27.

Robinson JW, Faris PD, Scott CB (1999) Psychoeducational group increases vaginal dilation for younger women and reduces sexual fears for women of all ages with gynecological carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 44:497–506. doi:10.1016/S0360-3016(99)00048-6 CrossRefPubMed

28.

Scott JL, Kayser K (2009) A review of couple-based interventions for enhancing women’s sexual adjustment and body image after cancer. Cancer 15:48–56. doi:10.1097/PPO.0b013e31819585df CrossRef

29.

Weijenborg PTM, ter Kuile MM (2000) The effect of a group programme on women with the Mayer-Rokitansky-Kuster-Hauser syndrome. BJOG 107:365–368. doi:10.1111/j.1471-0528.2000.tb13232.x CrossRefPubMed

30.

ter Kuile MM, Weijenborg PTM (2006) A cognitive-behavioral group program for women with vulvar vestibulitis syndrome (VVS): factors associated with treatment success. J Sex Marital Ther 32:199–213. doi:10.1080/00926230600575306 CrossRefPubMed

31.

Miller WR, Rollnick S (2012) Motivational interviewing: helping people change, 3rd ed. Guilford Press. ISBN 978–1–60918-227-4

32.

Palacio A, Garay D, Langer B, Taylor J, Wood BA, Tamariz L (2016) Motivational interviewing improves medication adherence: a systematic review and meta-analysis. J Gen Intern Med 31:929–940. doi:10.1007/s11606-016-3685-3 CrossRefPubMed

33.

Madson MB, Loignon AC, Lane C (2009) Training in motivational interviewing: a systematic review. J Subst Abus Treat 36:101–109. doi:10.1016/j.jsat.2008.05.005 CrossRef

34.

Ter Kuile MM, Melles RJ, de Groot HE, Tuijnman-Raasveld CC, van Lankveld JJDM (2013) Therapist-aided exposure for women with lifelong vaginismus: a randomized waiting-list control trial of efficacy. J Consult Clin Psych 81:1127–1136. doi:10.1037/a0034292 CrossRef

35.

van Lankveld JJDM, ter Kuile MM, de Groot HE, Melles R, Nefs J, Zandbergen M (2006) Cognitive-behavioral therapy for women with lifelong vaginismus: a randomized waiting-list controlled trial of efficacy. J Consult Clin Psych 74:168–178. doi:10.1037/0022-006X.74.1.168 CrossRef

36.

Baser RE, Li Y, Carter J (2012) Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors. Cancer 118:4606–4618. doi:10.1002/cncr.26739 CrossRefPubMed

37.

Derogatis LR, Rosen R, Leiblum S, Burnett A, Heiman J (2002) The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther 28:317–330. doi:10.1080/00926230290001448 CrossRefPubMed

38.

Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM (1997) A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 27:363–370. doi:10.1017/S0033291796004382 CrossRefPubMed

39.

Arrindell WA, Schaap C (1985) The Maudsley Marital Questionnaire (MMQ): an extension of its construct validity. Br J Psychiatry 147:295–299. doi:10.1192/bjp.147.3.295 CrossRefPubMed

40.

Cohen J (1988) Statistical power analysis for the behavioral sciences (2nd ed.). Lawrence Erlbaum Associates, Hillsdale, NJ

41.

Vermeer WM, Bakker RM, Kenter GG, de Kroon CD, Stiggelbout AM, ter Kuile MM (2015) Sexual issues among cervical cancer survivors: how can we help women seek help? Psychooncology 24:458–464. doi:10.1002/pon.3663 CrossRefPubMed

42.

Hertzog MA (2008) Considerations in determining sample size for pilot studies. Res Nurs Health 31:180–191. doi:10.1002/nur.20247 CrossRefPubMed

Title: A nurse-led sexual rehabilitation intervention after radiotherapy for gynecological cancer
Authors: R. M. Bakker
J. W. M. Mens
H. E. de Groot
C. C. Tuijnman-Raasveld
C. Braat
W. C. P. Hompus
J. G. M. Poelman
M. S. Laman
L. A. Velema
C. D. de Kroon
H. C. van Doorn
C. L. Creutzberg
M. M. ter Kuile
Publication date: 01-03-2017
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 3/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-016-3453-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2017

Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types

The “rocky treatment course”: identifying a high-risk subgroup of head and neck cancer patients for supportive interventions

Effects of a multimodal rehabilitation programme on inflammation and oxidative stress in oesophageal cancer survivors: the ReStOre feasibility study

Body weight changes in patients undergoing chemotherapy for ovarian cancer influence progression-free and overall survival

Participation in treatment decision-making among Chinese-Australian women with breast cancer

Mental and physical health correlates among family caregivers of patients with newly-diagnosed incurable cancer: a hierarchical linear regression analysis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer